Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-10 of 10
Keywords: Tumor marker
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Does Determining Tumor Markers from the Testicular Vein Enable Better Diagnosis and Prognosis?
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2021) 105 (3-4): 264–268.
Published Online: 17 December 2020
...Thomas Zauner; Stefan Heidler; Lukas Lusuardi; Walter Albrecht; Florian Wimpissinger Introduction: β-HCG has been the only tumor marker evaluated in testicular vein (VT) blood until now. Objective: To evaluate the correlation between the tumor markers β-HCG, AFP, PLAP, and LDH from the VT...
Journal Articles
Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2013) 91 (4): 456–461.
Published Online: 14 August 2013
... elevated sFas levels in the serum of patients with bladder cancer and suggested an association of elevated sFas level with poor prognosis in these patients. Conversely, Perabo et al. [ 11 ] argued that serum sFas seemed useless as a tumor marker and that it had limited relevance in laboratory...
Journal Articles
Clinical Usefulness of CEA, CA19-9, and CYFRA 21-1 as Tumor Markers for Urothelial Bladder Carcinoma
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2011) 87 (4): 420–428.
Published Online: 28 October 2011
...- and high-grade urothelial carcinoma of the bladder. It is useful for monitoring this disease and for predicting the prognosis. In contrast, the clinical usefulness of CEA and CA19-9 as tumor markers was not demonstrated. 12 04 2010 25 02 2011 28 10 2011 © 2011 S. Karger AG, Basel...
Journal Articles
Immunohistochemical Study of CA19-9 and SPan-1 in Cases of Hydronephrosis
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1996) 57 (2): 93–98.
Published Online: 04 February 2010
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CA19–9 SPan-1 Carbohydrate antigens Tumor marker Kidney Hydronephrosis Immunohistochemistry Urología Internationalls Original Paper Urol...
Journal Articles
Prognostication of Bladder Carcinoma by Immunohistochemistry: Refined and Combined Analysis of Staining for MCA and CA50
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1990) 45 (6): 361–366.
Published Online: 02 February 2010
...P.K. Lipponen; M.J. Eskelinen; Y. Collan The immunohistochemical reactivity of tumour markers MCA and CA50 was determined in transitional cell carcinoma of the bladder of WHO grades I–III. The material consisted of paraffin-embedded biopsies from bladder tumors in 83 patients. Mean follow-up time...
Journal Articles
Immunohistochemical Distribution of CA19-9 in Normal and Tumor Tissues of the Kidney
Available to PurchaseSubject Area:
Further Areas
Gakuji Ohshio, Katsuhiko Ogawa, Hiroyuki Kudo, Hirohiko Yamabe, Kayoko Higuchi, Yasuaki Nakashima, Tadao Manabe, Takayoshi Tobe
Journal:
Urologia Internationalis
Urol Int (1990) 45 (1): 1–3.
Published Online: 02 February 2010
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tumor marker CA19-9 Renal cell...
Journal Articles
Quantification of Alpha-Fetoprotein and Beta-HCG in Testis Tumor Patients
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1987) 42 (4): 248–253.
Published Online: 02 February 2010
...U. Dunzendorfer; C. Jurincic Patients with testis tumor were investigated for serum and tissue levels of alpha-fetoprotein and beta-human chorionic gonadotropin (beta-HCG). The tissue immune peroxidase-antiperoxidase staining for the tumor marker was quantitated by computer-assisted...
Journal Articles
Pyruvate Kinase Type Tumor M2 in Urological Malignancies
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2003) 70 (1): 55–58.
Published Online: 07 February 2003
...A. Hegele; Z. Varga; B. Kosche; T. Stief; A. Heidenreich; R. Hofmann Introduction: The dimeric form of pyruvate kinase type M2 is overexpressed in tumor cells (TuM2-PK). The aim of the present study was to evaluate the clinical value of TuM2-PK as a tumor marker for renal cell carcinoma (RCC...
Journal Articles
Alpha-Fetoprotein-Producing Renal Cell Carcinoma
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2001) 67 (2): 181–183.
Published Online: 10 August 2001
...V. Poulakis; U. Witzsch; R. de Vries; E. Becht; H.-M. Altmannsberger; S. Störkel Alpha-fetoprotein (AFP) is recognized as a tumor marker of yolk sac tumors, liver cancer and some other cancers of the digestive organs. Renal cell carcinoma (RCC) producing AFP is a rare entity. A case of AFP...
Journal Articles
Serum Ferritin as a Clinical Markerfor Renal Cell Carcinoma: Influenc e of Tumor Size and Volume
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1999) 62 (1): 21–25.
Published Online: 28 July 1999
...Ziya Kırkalı; Muhammet Güzelsoy; M. Uǧur Mungan; Güldal Kırkalı; Kutsal Yorukoglu Objectives: There is no established tumor marker for renal cell carcinoma (RCC). Ferritin is shown to be expressed by the tumor, and proposed as a tumor marker. The aim of this study is to assess the relation between...